Oculis Holding AG (OCS) Change in Cash (2022 - 2026)
Oculis Holding AG (OCS) posted quarterly Change in Cash of -$22.0 million for Q1 2026, down 159.36% year-over-year from $37.1 million in Q1 2025, and down 150.45% quarter-over-quarter from $43.7 million in Q4 2025.
Analysis
Oculis Holding AG (OCS) Change in Cash (2022 - 2026) Analysis & Trends
Oculis Holding AG's Change in Cash history runs 5 years deep, the most recent figure standing at -$22.0 million for Q1 2026.
- In Q1 2026, Change in Cash fell 159.36% year-over-year to -$22.0 million; the TTM figure through Mar 2026 stood at $10.5 million (down 74.29% YoY), while the FY2025 annual figure was $72.0 million, up 674.33% from the prior year.
- Change in Cash for Q1 2026 stood at -$22.0 million, down from $43.7 million in the prior quarter.
- The five-year high for Change in Cash was $86.1 million in Q1 2023, with the low at -$57.7 million in Q2 2023.
- The 5-year median for Change in Cash is -$8.1 million (2024), against an average of $2.8 million.
- The sharpest annual moves came in 2023 and 2025: Change in Cash slumped 205.76% in 2023, then surged 536.38% in 2025.
- Oculis Holding AG's Change in Cash stood at -$8.6 million in 2022, then soared by 219.37% to $10.3 million in 2023, then sank by 196.97% to -$10.0 million in 2024, then soared by 536.38% to $43.7 million in 2025, then tumbled by 150.45% to -$22.0 million in 2026.
- Business Quant data shows OCS's Change in Cash at -$22.0 million in Q1 2026, $43.7 million in Q4 2025, and -$22.2 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -185.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 374.50 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 427.25 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -2.94 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 225.59 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Oculis Holding AG | 634.75 Mn | 345.87 Mn | - | -4.64 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4.64 Mn |
| Mar 31, 2026 | -22.03 Mn |
| Dec 31, 2025 | 43.66 Mn |
| Sep 30, 2025 | -22.16 Mn |
| Jun 30, 2025 | 11.04 Mn |
| Mar 31, 2025 | 37.11 Mn |
| Dec 31, 2024 | -10.01 Mn |
| Sep 30, 2024 | -8.06 Mn |
| Jun 30, 2024 | 21.88 Mn |
| Mar 31, 2024 | -17.26 Mn |
| Dec 31, 2023 | 10.32 Mn |
| Sep 30, 2023 | -17.36 Mn |
| Jun 30, 2023 | -57.67 Mn |
| Mar 31, 2023 | 86.12 Mn |
| Dec 31, 2022 | -8.64 Mn |
| Sep 30, 2022 | -5.68 Mn |